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Abstract
We conducted an extensive set of empirical analyses to examine the effect of the number of events per
variable (EPV) on the relative performance of three different methods for assessing the predictive accuracy
of a logistic regression model: apparent performance in the analysis sample, split-sample validation, and
optimism correction using bootstrap methods. Using a single dataset of patients hospitalized with
heart failure, we compared the estimates of discriminatory performance from these methods to those
for a very large independent validation sample arising from the same population. As anticipated, the
apparent performance was optimistically biased, with the degree of optimism diminishing as the
number of events per variable increased. Differences between the bootstrap-corrected approach and
the use of an independent validation sample were minimal once the number of events per variable was
at least 20. Split-sample assessment resulted in too pessimistic and highly uncertain estimates of model
performance. Apparent performance estimates had lower mean squared error compared to split-sample
estimates, but the lowest mean squared error was obtained by bootstrap-corrected optimism estimates.
For bias, variance, and mean squared error of the performance estimates, the penalty incurred by using
split-sample validation was equivalent to reducing the sample size by a proportion equivalent to the
proportion of the sample that was withheld for model validation. In conclusion, split-sample validation
is inefficient and apparent performance is too optimistic for internal validation of regression-based
prediction models. Modern validation methods, such as bootstrap-based optimism correction, are
preferable. While these findings may be unsurprising to many statisticians, the results of the current
study reinforce what should be considered good statistical practice in the development and validation of
clinical prediction models.
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1 Introduction
Predicting the occurrence of an adverse event or outcome is important in clinical, population health,
and health services research. Clinical prediction models allow clinicians to assess patient prognosis
quantitatively and permit eﬀective risk stratiﬁcation of patients.
An important issue in developing a clinical prediction model is assessing how well it performs in
subjects who are similar to those used for model development.1 Throughout this paper, we use the
term ‘out-of-sample’ performance to denote the performance of the model in subjects who were not
used in model development, but who are similar to those used for developing the model. A simple
approach to validation is to assess the model’s apparent performance in the sample in which it was
derived. However, this usually results in optimistic estimates of performance, since the model is
optimized for performance in the sample in which it was derived. A commonly used approach is to
split randomly the sample into derivation and validation samples.2–4 The model is developed on the
derivation sample and its performance is subsequently evaluated on the validation sample. An
alternative approach that has been advocated by diﬀerent authors is to use bootstrap-based
methods for assessing model performance.5,6 While bootstrap-based methods for validating the
performance of prediction models have been shown to have desirable properties,7 many clinical
investigators may favour split-sample approaches, arguing that this approach has greater
transparency and face validity.
A key concept in the development of prediction models for binary outcomes is the number of
events per variable (EPV).8 When outcomes are binary, the number of events is the smaller of the
number of subjects who experienced the outcome and the number of subjects who did not experience
the outcome. The number of EPV is the number of events divided by the number of predictor
variables considered in developing the prediction model; strictly speaking, it is the number of
events divided by the number of degrees of freedom required to represent all of the variables in
the model. Thus, a three-level categorical variable would require two degrees of freedom. Similarly,
if a continuous variable was modelled using linear and quadratic terms then two degrees of freedom
would be required. Peduzzi et al. demonstrated that roughly 10 EPVs were required for accurate
estimation of regression coeﬃcients in a logistic regression model.8 In the related ﬁeld of
discriminant analysis, Lachenbruch and Goldstein suggest that it is suﬃcient to have three
subjects in each group for each parameter that is being estimated9 (p. 70). However, this required
number of subjects may increase or decrease depending on how separated the two groups are.
The objective of the studywas to compare the eﬀect of the number ofEPVwhendeveloping a clinical
prediction model on the relative performance of three methods for assessing the out-of-sample
accuracy of a prediction model: (i) the apparent performance in the sample in which it was derived,
(ii) split-sample derivation andvalidation, and (iii) bootstrap-basedmethods to correct the optimismof
the apparent performance of the model in the sample in which it was derived. Obviously, diﬀerences
between the methods would diminish as the number of EPV in the analytic sample increased and
stability would improve when the test sample was fairly large. We were speciﬁcally interested in
determining the value of the number of EPV at which diﬀerences between the methods were
negligible and in examining the relative eﬃciency of split-sample methods compared to competing
approaches such as bootstrap-based methods for optimism correction.
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The paper is structured as follows. In Section 2, we describe diﬀerent methods for assessing the
predictive accuracy of a clinical prediction model. In Section 3, we conduct an extensive series of
analyses to examine the eﬀect of the number of EPV on the relative performance of these diﬀerent
methods. Our analyses are based on examining a logistic regression model for predicting mortality
within 1 year of hospitalization for heart failure using a single clinical dataset. The performance of
each method was compared with that of the out-of-sample prediction of the model, when a very
large independent test sample other than the analytic sample was used for model validation. In
Section 4, we report the results of our analyses. In Section 5, we summarize our ﬁndings and place
them in the context of the existing literature.
2 Measuring the predictive accuracy of a logistic regression model
2.1 The c-statistic
When outcomes are binary, the c-statistic is the probability that a randomly selected subject who
experienced the outcome has a higher predicted probability of experiencing the outcome than a
randomly selected subject who did not experience the outcome. It can be calculated by taking all
possible pairs of subjects consisting of one subject who experienced the outcome of interest and one
subject who did not experience the outcome. The c-statistic is the proportion of such pairs in which
the subject who experienced the outcome had a higher predicted probability of experiencing the
event than the subject who did not experience the outcome (i.e. out of all possible pairs in which one
subject experiences the outcome and one subject does not experience the outcome, it is the
proportion of pairs that are concordant).5,6 The c-statistic is equivalent to the area under the
receiver operating characteristic curve and is a central measure of performance in many studies
on predicting binary outcomes.
2.2 Methods for estimating out-of-sample performance
We considered three diﬀerent methods for assessing the out-of-sample performance of a prediction
model. These methods each provide estimates of how well the model would predict outcomes in an
independent sample that originates from the same underlying population.
2.2.1 Apparent performance
A simple approach is to assess model performance directly in the sample in which it was developed.
Using the ﬁtted regression model, the predicted probability of the outcome is determined for each
subject in the analytic sample. A summary measure of model performance, such as the c-statistic, is
then reported. A limitation of this approach is that the model is optimized for performance in the
sample in which it was developed. Subsequent predictions in subjects who were not used in model
development are likely to have poorer accuracy than that which was reported in the analytic sample.
Apparent performance estimates are hence optimistic. The magnitude of optimism is expected to
decrease as the eﬀective sample size of the model derivation sample increases.
2.2.2 Split-sample assessment of performance
Using the split-sample approach, the sample is divided into two parts: a derivation sample and
a validation sample. Frequently, these two sub-samples are of the same size2 (p. 420), although using
two-thirds of the data for model derivation and one-third for model validation has also been used.
The prediction model is estimated in the derivation sample. The estimated model is then
applied to make predictions for subjects in the validation sample. The predictive accuracy of the
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model is estimated based on these predictions for the subjects in the validation sample. This
estimate of predictive accuracy in the validation sample is used as an estimate of out-of-sample
performance.
2.2.3 Bootstrap methods for optimism-corrected performance
A criticism of split-sample methods for estimating out-of-sample performance is that it is
relatively ineﬃcient due to its reduction of the size of both the sample used for model
development and for model validation.7 Furthermore, variability in the estimated performance
can be induced through the reliance on a single split of the sample in derivation and validation
components. A popular method for correcting the inherent optimism in estimates of model
performance obtained on the same sample used to develop the model is based on the
bootstrap.1,5,6,10 To do so, one develops a prediction model in the analytic sample
(the original sample). One then assesses the apparent performance of the estimated model in
the analysis sample in which it was derived. As above, this is denoted as the apparent
performance. One then draws a bootstrap sample with replacement from the original analysis
sample and develops a prediction model in this bootstrap sample. Care should be given to
perform all the steps that were taken to develop the original prediction model, such as
selection of predictors and estimation of regression coeﬃcients. We record the performance of
this model (the bootstrap model) on the bootstrap sample in which it was developed (i.e. the
apparent performance of the bootstrap model in the bootstrap sample). We then apply the
bootstrap model to the analytic sample to obtain an estimate of its out-of-sample
performance. The optimism is deﬁned as the diﬀerence between the bootstrap performance
(apparent performance of the bootstrap model) and its out-of-sample performance. This
bootstrap process is then repeated at least 100 times. Model optimism is then averaged across
all the bootstrap iterations. As a ﬁnal step, one then subtracts the optimism estimate from the
apparent performance to obtain the optimism-corrected performance estimate.
3 Methods
We used a series of empirical analyses to examine the eﬀect of the number of EPV on the relative
performance of diﬀerent methods for assessing the out-of-sample predictive accuracy of a logistic
regression model. In this section, we describe the data that were used for these analyses, the clinical
prediction model, and the statistical analyses.
3.1 Data source
The Enhanced Feedback for Eﬀective Cardiac Treatment (EFFECT) Study was a study designed to
improve the quality of care provided to patients with cardiovascular disease in Ontario, Canada.11
During the study, detailed clinical data on patients hospitalized with congestive heart failure
between 1 April 1999 and 31 March 2001 (Phase 1) and between 1 April 2004 and 31 March
2005 (Phase 2) at 103 hospitals in Ontario, Canada were obtained by retrospective chart review.
Data on patient demographics, vital signs and physical examination at presentation, medical history,
and results of laboratory tests were collected. The EFFECT-HF sample consisted of 18,284 patients.
Of these, 255 patients on dialysis were excluded, since the clinical prediction model under
consideration was not intended for use on these patients. Of the remaining 18,029 patients, an
additional 1792 patients with missing data on baseline covariates that were necessary to estimate
the clinical prediction model were excluded. This left a total of 16,237 patients for analysis (8521
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patients in Phase 1 and 7716 patients in Phase 2). Within 1 year of hospital admission, 5181 (31.9%)
patients died. The exclusion of patients with missing data was done for pragmatic reasons.
This exclusion was unlikely to have an impact on our conclusions as we used random samples
from the overall analytic sample to estimate and validate prediction models. In applied clinical
research studies, investigators may want to consider more sophisticated statistical approaches,
such as multiple imputation, when addressing the issue of missing data. In applying an existing
clinical prediction model to patients who are missing data on some of the necessary predictor
variables, the user should consider using available methods for imputing these missing predictor
variables.
3.2 Clinical prediction model
We examined the performance of the EFFECT-HF mortality prediction model, which uses 11
variables to predict the probability of 1-year mortality.12 The prediction model includes four
continuous variables: age, respiratory rate, systolic blood pressure, and urea nitrogen and seven
dichotomous variables: sodium concentration <136mEq/l, haemoglobin <10.0 g/dl,
cerebrovascular disease, dementia, chronic obstructive pulmonary disease, hepatic cirrhosis, and
cancer. The four continuous covariates were all modelled as linear, continuous covariates. Prior
studies that found that the use of ﬂexible methods to model non-linear relationships between
continuous covariates and the log-odds of the outcome resulted in very minor improvements in
model accuracy for predicting mortality in cardiovascular patients.13,14 In the data used for the
current analyses, only 120 (0.74%) patients had hepatic cirrhosis. In some of the analyses, this
resulted in analytic samples in which no patients had hepatic cirrhosis. For this reason, we
excluded hepatic cirrhosis as a covariate from the prediction model (the exclusion of such a
variable with a very low prevalence is discussed in Section 5). Thus, the prediction model had 10
predictor variables. The distribution of each of the 10 predictor variables is summarized in Table 1,
along with the adjusted odds ratio for death within 1 year of hospitalization.
Table 1. Distribution of risk factors in the clinical prediction model and odds ratios for 1-year mortality.
Variable
Distribution (median/
(1st, 25th, 75th, and
99th percentiles) or %)a
Odds ratio for 1-year
mortality (95%
confidence interval)
Age 78 (44, 70, 84, 97) 1.041 (1.037–1.045)
Respiratory rate (breaths per minute) 24 (20, 20, 28, 45) 1.025 (1.019–1.031)
Systolic blood pressure (beats per minute) 145 (90, 124, 169, 200) 0.987 (0.985–0.988)
Urea nitrogen 8.4 (2.9, 6.1, 12.2, 20.0) 1.104 (1.096–1.113)
Sodium concentration <136mEq/l 21.3% 1.365 (1.253–1.487)
Haemoglobin <10.0 g/dl 12.7% 1.196 (1.076–1.329)
Cerebrovascular disease 17.4% 1.323 (1.207–1.450)
Dementia 9.0% 2.132 (1.892–2.402)
Chronic obstructive pulmonary disease 25.0% 1.297 (1.194–1.408)
Cancer 11.6% 1.663 (1.495–1.849)
aContinuous variables are reported as medians (1st, 25th, 75th, and 99th percentiles). Dichotomous variables are reported as the
percentage of subjects with the condition.
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3.3 Statistical analyses
We conducted a series of analyses to compare the eﬀect of the number of EPV in the study sample
on the agreement between the true out-of-sample performance of the model with estimates obtained
using diﬀerent methods to estimate out-of-sample performance.
We allowed the empirical or observed number of EPV in the analysis sample to range from 5 to 100
in increments of 5. In the EFFECT-HF sample described earlier, there were 16,237 subjects and the
1-year mortality rate was 31.9%. The EFFECT-HFmortality prediction model contains 10 variables.
For a given number of EPV, we would require 10EPV events in the analysis sample. Given the
observed 1-year event rate of 0.319, an analysis sample of size 10EPV/0.319 would be expected to
have the required number of EPV. We then drew a random sample of size 10EPV/0.319 from the
EFFECT-HF sample. We refer to this random sample as the analysis sample. We calculated the
observed number of EPV in the randomly selected sample. If, when rounded to the nearest integer,
it was equal to the desired number of EPV, the random selected sample was retained, otherwise it
was discarded and random samples were drawn until one with the desired observed number of EPV
was drawn. The remainder of the EFFECT-HF (those subjects not included in the analysis sample)
was used for model validation. Performance in the validation sample of a model estimated in the
analysis sample was used as the estimate of the true out-of-sample performance of the regression
model. Since the number of EPV ranged from 5 to 100, the size of the analysis samples ranged from
157 to 3135, while the size of the independent validation sample ranged from 16,080 to 13,101. The
decision to use the remainder of the EFFECT-HF sample as the validation sample (regardless of its
sample size in a given EPV scenario) was made for reasons of accuracy and precision. This allowed for
the estimation of the out-of-sample performance with the greatest accuracy and precision.
Once a given analysis sample and validation sample were selected, the following statistical
analyses were conducted:
(1) The EFFECT-HF mortality prediction model was estimated in the entire analysis sample. The c-
statistic of the model was estimated. This is the apparent performance of the model in the
sample in which it was derived.
(2) Split-sample validation was used to assess model performance. The analysis sample was
randomly split into two equally sized components: a derivation sample and a validation
sample. The coeﬃcients for the EFFECT-HF model were estimated in the derivation sample.
These coeﬃcients were then applied to the validation sample and predicted probabilities of the
occurrence of the outcome were determined for each subject. The c-statistic of the estimated
model was computed using the estimated probabilities in the validation sample.
(3) The coeﬃcients of the EFFECT-HF model were estimated in the entire analysis sample and the
apparent performance of the model was estimated using the c-statistic (as in the ﬁrst analysis
described earlier). Bootstrap methods were then used to derive an optimism-corrected measure
of model performance. One hundred bootstrap iterations were used to compute the optimism-
corrected measure of performance. As a sensitivity analysis, we performed analyses with 500
bootstrap iterations for EPV 5, 10, 15, and 20.
(4) The predicted probability of 1-year mortality was estimated for each subject in the independent
validation data using the regression model estimated in the entire analysis sample (the model
estimated in the ﬁrst analysis described earlier). This estimate served as the true out-of-sample
performance estimate.
For a given value of the number of EPV (5–100 in increments of 5), the above analyses were repeated
1000 times (i.e. for each number of EPV, we drew sequential random samples until 1000 were
Austin and Steyerberg 801
obtained with the desired number of EPV). For each value of the observed number of EPV,
we summarized the analyses as follows. First, we computed the mean c-statistic obtained using
each of the four analyses described earlier across all iterations with the observed number of EPV,
with the standard deviation used to describe variability. Second, we computed the mean squared
error (MSE) of the c-statistic estimated using each of the three methods described earlier. For a
given value of the number of EPV, we used the estimate of the c-statistic determined in (4) earlier
(when averaged across the 1000 iterations of the analysis) as the true value of the c-statistic when
applied to an independent validation sample. The MSE of the estimated c-statistics was then
determined as 11, 000
P1,000
i¼1 ci  ctrueð Þ2, where ci denotes the estimated c-statistic in the ith iteration
of the analysis.
4 Results
The relation between the number of EPV and the mean estimated c-statistic for each of the three
analytic methods is described in Figure 1. We superimposed an additional line representing the mean
c-statistic of the model estimated in the full analytic sample when applied to the independent
validation sample as a reference to which each of the other methods can be compared.
Furthermore, the horizontal line denotes the apparent performance of the prediction model when
estimated in the entire EFFECT-HF sample. In examining this ﬁgure, several observations warrant
comment. The use of the apparent performance of the prediction model in the analysis sample
resulted in an overly optimistic estimate of the predictive accuracy of the estimated model, as was
theoretically expected. Even when the number of EPV was very large, this method resulted in
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Figure 1. Mean estimated cstatistic for different validation methods.
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estimates of performance that were modestly optimistic compared to estimates derived from the
other approaches. For instance, when the number of EPV was 100, the mean c-statistic from the
apparent performance of the model in the analysis sample was 0.746, whereas the mean out-of-
sample estimate of the c-statistic was 0.741. When the number of EPV was 10, the mean apparent
performance was 0.763, while the mean out-of-sample estimate of performance was 0.725. In
contrast, split-sample assessment of performance resulted in estimates of performance that were
overly pessimistic. The magnitude of pessimism was substantial when the number of EPV was less
than or equal to 20 (compared with external validation, the pessimism ranged from 0.034 for
EVP¼ 5 to 0.009 for EPV¼ 20). Furthermore, the use of bootstrap-corrected estimates of
performance and an external validation sample tended to result in essentially indistinguishable
estimates of performance when the number of EPV was equal to or greater than 20. When the
number of EPV was less than 20, then the use of bootstrap correction resulted in estimates of
performance that were modestly greater than those obtained using an independent validation
sample. Since the horizontal line denotes the apparent performance of the prediction model in the
full EFFECT-HF sample (N¼ 16,237 and 5181 deaths) (c-statistic¼ 0.743), it is also the asymptote
to which all methods appear to be converging as the number of EPV increases. Because of the large
sample size and favourable EPV value, it is reasonable to take this number as the true performance
of the model. Under this assumption, it appears that when the number of EPV is less than 20, then
bootstrap-corrected measures of performance are closest to those obtained using an independent
validation sample. When the number of EPV was less than or equal to 20, the use of 500 bootstrap
samples yielded essentially identical results to when 100 bootstrap samples were used.
In order to examine further the penalty incurred by using split-sample validation, we
superimposed a line on Figure 1 of the estimated c-statistic obtained using split-sample validation
against the number of EPV divided by two (i.e. by using the expected number of EPV in the
derivation sample). This shifts the original curve for the results from split-sample validation to
the left. Thus, the range of this curve is from 2.5 to 50 EPV. This line is very similar to the two
curves obtained using bootstrap correction and the independent validation sample. Thus, the bias in
estimating the c-statistic using split-sample methods with an analysis sample of a given size is
approximately equal to the observed bias when using bootstrap correction with a sample of half
that size. In other words, the penalty incurred by using split-sample validation is that one halves the
sample size in the analysis sample.
From Figure 2 we note that the use of an external validation sample resulted in the lowest
variability in the estimated c-statistic across the 1000 iterations of the analyses. This assessment
merely reﬂects uncertainty of the developed models, rather than uncertainty in the validation data
sets, which were of large size. Conversely, split-sample assessment resulted in the greatest variability
in estimating performance. When the number of EPV was less than 40, then the use of the apparent
performance in the analysis sample displayed modestly less variability than displayed by the
estimates produced using bootstrap correction. As above, we superimposed on Figure 2 a plot of
the standard deviation of the estimated c-statistic obtained using split-sample validation against the
number of EPV divided by two. Again, we note that the lines for split-sample methods agree with the
line for bootstrap correction with a sample of half that size.
The relation between the number of EPV and the MSE of the three diﬀerent methods for
estimating the performance of the prediction model is described in Figure 3. Split-sample
assessment resulted in estimates of performance with the highest MSE, while bootstrap-corrected
optimism resulted in estimates with the lowest MSE. Interestingly, the use of the apparent
performance in the analysis sample resulted in estimates with lower MSE than did the use of
split-sample assessment.
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5 Discussion
We conducted an extensive set of empirical analyses to examine the eﬀect of the number of EPV on
the relative performance of three diﬀerent methods for assessing the predictive accuracy of a logistic
regression model. We conﬁrmed that the use of apparent performance resulted in an optimistic
assessment of model performance, with a bias over 0.005 in c statistic until EPV¼ 100. A
bootstrap-corrected approach had the lowest MSE. The use of split-sample assessment resulted in
too pessimistic an assessment of model performance. Furthermore, the use of split-sample
assessment resulted in the greatest variability in assessing the performance of the prediction
model. Remarkably, the use of the apparent performance resulted in estimates with lower MSE
compared to the use of split-sample estimation. For bias, variance and MSE of the estimated c-
statistic, the penalty incurred by using split-sample validation in the analysis sample was
approximately equal to reducing the observed number of EPV by a proportion equivalent to the
proportion of the sample that was withheld for model validation.
There are important implications of our results for clinical investigators developing and
validating clinical prediction models. First, our perception is that many clinical investigators
prefer to use a split-sample method to assess the performance of the derived model. While clinical
investigators may favour split-sample assessment on clinical grounds, our results suggest that the use
of split-sample assessment should be discouraged on statistical grounds. The split-sample approach
results in far too pessimistic and unstable estimates of performance, while we can readily use modern
methods such as the bootstrap to correct for the optimism in apparent performance estimates. The
penalty of substantially reducing the eﬀective sample size likely outweighs arguments such as greater
transparency and face validity. Second, clinical investigators frequently do not have the luxury of
having a second, independent, sample arising from the same population for use as an external
validation sample. Our results, based on empirical analyses conducted in a single dataset,
demonstrate that once the number of EPV is at least 20 in the analytic sample, then bootstrap-
corrected assessment of performance will likely coincide with the assessment of performance if an
independent sample from the same population were available. Even when the number of EPV is less
than this number, the diﬀerences between the two approaches tended to be minimal (e.g. diﬀerence
in mean c-statistic was approximately 0.004 when the number of EPV was equal to 10). The primary
advantage to the use of an independent validation sample from the same population is the decreased
variability in the estimated performance of the derived model.
The ﬁndings of the current study are in line with those from an earlier study comparing diﬀerent
methods of assessing model performance.7 However, there are several important reasons for
retaining a focus on the same issue: ﬁrst, in the 13 years since the publication of the earlier study,
split-sample validation continues to be a popular and frequently implemented approach. Thus, it is
important to explore further and highlight its limitations. Second, one of our secondary objectives
was to examine the number of EPV at which the use of the bootstrap for optimism correction had a
similar performance to true out-of-sample validation. Third, in the current study, we determined the
approximate penalty in the number of EPV that was incurred by using split-sample validation
compared to using bootstrap-corrected optimism.
Berk suggested that the best way to validate the predictive accuracy of a model is to apply it to
new data.15 Snee agreed that application of the derived model to new data is the preferred approach
to model validation.2 However, he suggests that this is often impractical or is not feasible. As an
alternative, he suggested that a reasonable approach would be to use split-sample validation.
Furthermore, Snee suggests that using half the data for model development and half the data for
model validation appears to be the most popular method (p. 420). In the context of ordinary least
squares regression, Picard and Berk provide guidelines for the proportion of the available data that
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should be used for model development, with the remainder being reserved for model validation.4
They suggested that the neglect of the use split-sample validation was due to a ‘wide-spread (and
often mistaken) notion that data splitting is grossly ineﬃcient for both prediction and validation’
(p. 140). Our ﬁndings show that split-sample validation is quite ineﬃcient compared to bootstrap-
corrected assessment of performance. Furthermore, split-sample validation even had greater MSE
compared to the MSE of the naı¨ve apparent performance of the model in the sample in which it was
developed. Picard and Berk do characterize an important limitation of bootstrap-based methods for
assessing performance (p. 143). They suggest that it may be diﬃcult to automate speciﬁc steps in
model development that involved subjective human judgment or decisions (e.g. decisions about
applying range constraints to certain variables based on graphical displays or about whether to
employ a non-linear or linear relationship between a given continuous covariate and the outcome).
Indeed, we considered a pre-speciﬁed 10 predictor model, while models may be often selected based
on ﬁndings in the analytical sample. Various methods may be used. Some, such as stepwise selection,
can readily be included in bootstrap procedures, while others may be more diﬃcult to repeat
systematically, such as graphical inspections of data for outliers or non-linearities.
There are certain other limitations to the current study. First, in our simulations, we did not
consider all possible methods for estimating the out-of-sample performance of a prediction model.
Our focus was on comparing the performance of split-sample validation with that of methods based
on bootstrap correction. Our comparisons were motivated by the observation that split-sample
validation is frequently used in the biomedical literature and that bootstrap correction has been
proposed as a promising alternative.1 Two recently discussed methods are the ‘leave-one-out’ and
‘leave-pair-out’ methods described byAirola et al.16 (the leave-one-out approach dates back to at least
1968, when it was examined by Lachenbruch and Mickey in the context of discriminant analysis17).
Given the number of sub-samples in which the candidate model must be ﬁt, it was not feasible to
examine the performance of these two approaches using the sample sizes that were used in the current
study. In a recent study, Smith et al. used a set of empirical analyses in two datasets to compare the
performance of diﬀerent methods for optimism correction when the number of EPV was equal to 5
(i.e. when the number of EPV was very low).18 They found that the ‘leave-one-out’ approach resulted
in estimates of the c-statistics that were systematically lower than the true c-statistic. Both bootstrap
correction, ‘leave-pair-out’, and 10-fold cross-validation (both with and without replication) resulted
in estimated c-statistics that did not diﬀer signiﬁcantly from the true value. A second limitation was
our exclusion of the variable denoting hepatic cirrhosis from the clinical prediction model. This was
done due to the low prevalence of patients with this condition, which resulted in some of the derivation
samples having no patients with this condition. An alternative approach would be to use stratiﬁed
sampling for model development and a stratiﬁed bootstrap for validation, with strata formed by the
infrequent covariate. However, the behaviour of such a procedure requires further study prior to its
widespread implementation. A diﬀerent approach would be to use methods from the data mining and
machine learning literature, such as regression trees, random forests, or boosted regression trees,19–22
which do not require that the variable display variability in all samples. Regardless of the method
used, we would note that, in general, rare characteristics are of interest only if they have a strong
eﬀect.23,24 A third limitation was our focus on the c-statistic for assessing model performance.
Other measures of model performance such as the generalized R2N index and the Brier Score have
been proposed for evaluating the performance of logistic regression models.5 In the current study,
we have focused on the c-statistic due to its popularity for quantifying the performance of clinical
prediction models. A fourth limitation was that our study was based on empirical analyses conducted
in a single dataset. As such, our methods warrant replication in diﬀerent settings to conﬁrm the
generalizability of our ﬁndings.
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Validation of the performance of clinical prediction models is an important component to assess
alongside their development. Validation of such models allows investigators and clinicians to
understand the accuracy of these models in patients who were not used in model development.
Patients may be rather similar to those in whom the model was developed (internal validation),
or diﬀer in aspects such as time and place of treatment, allowing us to study generalizability
(external validation).1 Split-sample validation is a popular method in the clinical literature for
model validation, but does not deserve such popularity. The penalty incurred by split-sample
validation is approximately equal to a reduction of the sample size by a proportion equivalent to
the proportion of the sample that was withheld for model validation. We encourage the use of
modern validation procedures, such as bootstrap optimism correction in studies of model
development.
Acknowledgements
This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual
grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and
conclusions reported in this paper are those of the authors and are independent from the funding sources.
No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. This research was
supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (MOP 86508).
Dr Austin is supported in part by a Career Investigator award from the Heart and Stroke Foundation
Ontario Oﬃce. Dr Steyerberg is supported in part by a U award (AA022802, value of personalized risk
information). The Enhanced Feedback for Eﬀective Cardiac Treatment (EFFECT) data used in the study
was funded by a CIHR Team Grant in Cardiovascular Outcomes Research. These datasets were linked
using unique, encoded identiﬁers and analysed at the Institute for Clinical Evaluative Sciences (ICES).
Declaration of conflicting interests
The author(s) declared no potential conﬂicts of interest with respect to the research, authorship, and/or
publication of this article.
Funding
The author(s) received no ﬁnancial support for the research, authorship, and/or publication of this article.
References
1. Justice AC, Covinsky KE and Berlin JA. Assessing the
generalizability of prognostic information. Ann Intern Med
1999; 130: 515–524.
2. Snee RD. Validation of regression models: methods and
examples. Technometrics 1977; 19: 415–428.
3. Hastie T, Tibshirani R and Friedman J. The elements of
statistical learning. Data mining, Inference, and prediction.
New York, NY: Springer-Verlag, 2001.
4. Picard RR and Berk KN. Data splitting. Am Statist 1990;
44: 140–147.
5. Harrell FE Jr. Regression modeling strategies. New York,
NY: Springer-Verlag, 2001.
6. Steyerberg EW. Clinical prediction models. New York:
Springer-Verlag, 2009.
7. Steyerberg EW, Harrell FE Jr, Borsboom GJ, et al.
Internal validation of predictive models: efficiency of some
procedures for logistic regression analysis. J Clin Epidemiol
2001; 54: 774–781.
8. Peduzzi P, Concato J, Kemper E, et al. A simulation study
of the number of events per variable in logistic regression
analysis. J Clin Epidemiol 1996; 49: 1373–1379.
9. Lachenbruch PA and Goldstein M. Discriminant analysis.
Biometrics 1979; 35: 69–84.
10. Efron B and Tibshirani RJ. An introduction to the
bootstrap. New York, NY: Chapman & Hall, 1993.
11. Tu JV, Donovan LR, Lee DS, et al. Effectiveness of public
report cards for improving the quality of cardiac care: the
EFFECT study: a randomized trial. J AmMed Assoc 2009;
302: 2330–2337.
12. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality
among patients hospitalized for heart failure: derivation
and validation of a clinical model. J Am Med Assoc 2003;
290: 2581–2587.
Austin and Steyerberg 807
13. Austin PC. A comparison of regression trees, logistic
regression, generalized additive models, and multivariate
adaptive regression splines for predicting AMI mortality.
Stat Med 2007; 26: 2937–2957.
14. Austin PC, Lee DS, Steyerberg EW, et al. Regression trees
for predicting mortality in patients with cardiovascular
disease: what improvement is achieved by using ensemble-
based methods? Biometric J 2012; 54: 657–673.
15. Berk KN. Validating regression procedures with new data.
Technometrics 1984; 26: 331–338.
16. Airola A, Pahikkala T, Waegeman W, et al. An
experimental comparison of cross-validation techniques
for estimating the area under the ROC curve. Comput Stat
Data Anal 2011; 55: 1828–1844.
17. Lachenbruch PA and Mickey MR. Estimation of error
rates in discriminant analysis. Technometrics 1968; 10:
1–11.
18. Smith GC, Seaman SR, Wood AM, et al. Correcting for
optimistic prediction in small data sets. Am J Epidemiol
2014; 180: 318–324.
19. Breiman L, Friedman JH, Olshen RA, et al. Classification
and regression trees. Boca Raton: Chapman & Hall/CRC,
1998.
20. Breiman L. Random forests. Mach Learn 2001; 45: 5–32.
21. Buhlmann P and Hathorn T. Boosting algorithms:
regularization, prediction and model fitting. Stat Sci 2007;
22: 477–505.
22. Freund Y and Schapire R. Experiments with a new
boosting algorithm. In: Machine learning: proceedings of
the thirteenth international conference. San Francisco, CA:
Morgan Kauffman, 1996, pp.148–156.
23. Austin PC and Steyerberg EW. Interpreting the
concordance statistic of a logistic regression model:
relation to the variance and odds ratio of a continuous
explanatory variable. BMC Med Res Methodol 2012; 12:
82.
24. Austin PC and Steyerberg EW. Predictive accuracy of risk
factors and markers: a simulation study of the effect of
novel markers on different performance measures for
logistic regression models. Stat Med 2013; 32: 661–672.
808 Statistical Methods in Medical Research 26(2)
